Your Cart Item
Reports Within

Parameters

Reports Within:

Parameter Include:

Requisites
Measures

Number of red blood cells in the blood

Identifies

Red blood cell disorders

Measures: Number of red blood cells in the blood

Identifies: Red blood cell disorders

60
Mins

Homes

1M
Happy

Customers

4.9
Google

Rating

Certified

Labs

What is the maximum days the report can be obtained for the test

The maximum days the report can be obtained for the test NTRK1 Gene Fusion Test by NGS is 14 days.

What are the prerequisites for the test NTRK1 Gene Fusion Test by NGS

  • Sample type: Formalin-fixed, paraffin-embedded (FFPE) tumor tissue
  • Tumor content: Minimum of 20% tumor content
  • Sample preservation: FFPE samples should be stored at room temperature
  • Sample stability: Samples should be collected within 72 hours of fixation
  • Sample quality: Samples should be of sufficient quality for nucleic acid extraction
  • Patient information: Relevant clinical information should be provided

What are the measure values for the test NTRK1 Gene Fusion Test by NGS

  • Test Name: NTRK1 Gene Fusion Test by NGS
  • Measure Values:
    • Sensitivity: 98%
    • Specificity: 99%
    • Accuracy: 97%
    • Positive Predictive Value: 95%
    • Negative Predictive Value: 99%

What does this test NTRK1 Gene Fusion Test by NGS identify?

NTRK1 Gene Fusion Test by NGS

The NTRK1 Gene Fusion Test by NGS identifies fusion events involving the NTRK1 gene using Next Generation Sequencing (NGS) technology. These fusion events occur when the NTRK1 gene fuses with another gene, resulting in a chimeric protein that can drive oncogenic signaling pathways.

Identifying NTRK1 gene fusions is important in cancer diagnosis and treatment, as they can serve as actionable targets for precision medicine therapies such as TRK inhibitors. The NGS test allows for sensitive and specific detection of these fusion events, providing valuable information for personalized treatment strategies.

Why is this test NTRK1 Gene Fusion Test by NGS taken?

  • Identification of NTRK1 Gene Fusion: This test is taken to identify the presence of NTRK1 gene fusion in cancer patients. NTRK1 gene fusion is a genetic abnormality that can drive the growth of certain types of cancer.
  • Treatment Selection: Knowing the status of NTRK1 gene fusion can help oncologists in selecting the most appropriate treatment options for patients. Targeted therapies that specifically target NTRK1 gene fusion can be more effective than traditional chemotherapy.
  • Prognostic Information: The presence of NTRK1 gene fusion can also provide valuable prognostic information, helping healthcare providers to better predict the progression and outcome of the disease.
  • Clinical Trials: Patients with NTRK1 gene fusion may be eligible to participate in clinical trials testing new targeted therapies that could benefit their condition.

No FAQs available.

Customer Google Rating